Financial statements Hempoptima
Company suspended its operations from 2024-08-01
Balance sheet data of HEMPOPTIMA
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 364 410,99 | 269 124,14 | 266 043,67 |
| A. Fixed assets | 36 362,00 | 189 410,71 | 182 687,85 |
| B. Current assets | 283 048,99 | 69 713,43 | 83 355,82 |
| C. Share capital contributions (basic funds) | 45 000,00 | 10 000,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 |
| Total liabilities | 364 410,99 | 269 124,14 | 266 043,67 |
| A. Equity | 361 454,88 | 263 421,20 | 198 851,83 |
| B. Liabilities and provisions for liabilities | 2 956,11 | 5 702,94 | 67 191,84 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.